Unique Plan Description: Extravasation Treatment
Plan Selection Display: Extravasation Treatment
PlanType: Medical                                 
Version: 1          
Begin Effective Date: 2024-11-04 11:39:00
End Effective Date: 2100-12-31 00:00:00
Last Updated Date: 2025-01-14 12:16:12
Available at all facilities: Yes

Extravasation Treatment
Medications
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY background-color: rgb(232,235,245);margin:0; P margin:0 </STYLE><META name=GENERAT(NOTE)*
	hyaluronidase
		150 units/mL, Injection, SUBCUTANEOUS, Once
			Comment: Using a 25-gauge needle, inject subcutaneously, 4-5 separate 0.2mL injections around the extravasation site. Change the needle after each injection. Administer within 1 hour of extravasation.  Inject the antidote into the subcutaneous tissue. Avoid Z-tracking.
	phentolamine
		5 mg, Injection, SUBCUTANEOUS, Once
			Comment: Dilute phentolamine with 1mL of sterile water and QS to 5mL with sodium chloride for a 1mg/mL solution. Give as separate 0.5-1mL injections around the periphery of the infiltration site. Use a 25g needle and change after each injection; administer within 12hours of infiltration.  Inject the antidote into the subcutaneous tissue. Avoid Z-tracking.
	nitroglycerin 2% topical ointment
		1 in, Packet, TOPICAL, Q8H, PRN see comment, duration: 24 hr
			Comment: apply to extravasation site
Patient Care
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY background-color: rgb(232,235,245);margin:0; P margin:0 </STYLE><META name=GENERAT(NOTE)*
	Cold Therapy
		T;N, Ice bag
			Comment: apply for 15min increments. Heat/cold therapy technique based on nursing policy/Elsevier skills
	Heat Therapy
		T;N, Warm dry
			Comment: Apply for 20min increments q4h PRN. Heat/cold therapy technique based on nursing policy/Elsevier skills
	Discontinue
		T;N, Stop Administration of vesicant and/or IV fluids associated with affected site. Remove and Discontinue IV after attempting to aspirate residual vesicant.
	Notify MD
		T;N, Notify Provider of event at the time of occurrence
	Communication to HOSPITAL RN
		To administer the antidote subcutaneously, discontinue IV catheter. Avoid putting excess pressure on the site. Use 25-gauge, 1 inch needles (change needle with each injection)
	Integumentary Assessment-Focused
		T;N, Q4H-Sch, 24, hr
			Comment: Assess Extravasation site

*Report Legend:
DEF - This order sentence is the default for the selected order
GOAL - This component is a goal
IND - This component is an indicator
INT - This component is an intervention
IVS - This component is an IV Set
NOTE - This component is a note
Rx - This component is a prescription
SUB - This component is a sub phase